Navigation Links
Beckman Coulter Announces Third Quarter 2009 Results
Date:10/29/2009

192.3 215.2 Restructuring and acquisition related costs 79.2 7.8 127.2 13.2 Environmental remediation - 19.0 - 19.0 Total operating costs and expenses 373.5 310.8 934.0 872.9 Operating income 4.4 38.2 119.9 171.8 Non-operating (income) expense Interest income (1.4) (2.4) (4.0) (8.6) Interest expense 24.3 16.7 52.7 44.5 Other, net (18.0) (2.0) (24.9) (5.5) Total non-operating expense 4.9 12.3 23.8 30.4 Earnings before income taxes (0.5) 25.9 96.1 141.4 Income tax (benefit) provision (2.0) 1.8 13.2 30.5 Net earnings $1.5 $24.1 $82.9 $110.9 Basic earnings per share $0.02 $0.38 $1.27 $1.76 Diluted earnings per share $0.02 $0.37 $1.26 $1.72 Weighted average number of shares outstanding (in thousands) Basic 67,946 62,789 65,127 62,931 Diluted 69,372 64,334 66,033 64,403

                              BECKMAN COULTER, INC.
                    CONDENSED CONSOLIDATED BALANCE SHEETS
                                 (in millions)
                                  (unaudited)


                                              September 30,    December 31,
                                                  2009             2008
                                                  ----             ----
    Assets
    Current assets
      Cash and cash equivalents                  $262.3           $120.0
      Trade and other receivables, net            804.9            706.7
      Inventories                      
'/>"/>
SOURCE Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
2. Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers
3. Beckman Coulter to Present at Upcoming Healthcare Conferences
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... LONDON , May 22, 2015 ... early phase clinical research unit with a worldwide ... respected for its frequent publications in peer reviewed ... and European stakeholders and regulators in discussions about ... results.      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , ...
(Date:5/21/2015)... May 21, 2015 ... announced the addition of the "North ... Replacement, Digit Replacement, Elbow Replacement, Hip Replacement, ... 2019" report to their offering. ,     ... replacement was valued at $4,470.9 million in ...
(Date:5/21/2015)... , May 21, 2015 ... announced the addition of the "Market Assessment ... Europe" report to their offering. ,     (Logo: ... of the respiratory imaging diagnostics market in ... Europe . The service provides detailed ...
Breaking Medicine Technology:North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2United States and Europe Respiratory Diagnostics Market Assessment 2015 2
(Date:5/25/2015)... 25, 2015 Burke Rehabilitation Hospital ... Architects in New York City, to speak at Burke on ... hospital’s ongoing Legacy Lobby Lecture series, will take place at ... is the great grandson of Stanford White of McKim, Mead ... of Burke’s campus 100 years ago. , “We are thrilled ...
(Date:5/24/2015)... Kong (PRWEB) May 25, 2015 Pacific Prime has ... three part report looking at the cost of individual international ... Destinations, Article 2 looks at the cost of health insurance in ... , Focusing on, Hong Kong , ... the UAE , the UK ...
(Date:5/24/2015)... May 24, 2015 Women's Excellence ... hair loss. Although it is unclear about the etiology ... environmental factors such as metabolism, nutritional deficiencies, thyroid abnormalities ... offer a comprehensive approach to evaluating the metabolic, nutritional ... they can help patients find a cause for their ...
(Date:5/24/2015)... May 24, 2015 Women’s Excellence ... take pressure measurements in patients’ bladder and urethra. This ... orders it if they have reported symptoms of stress ... , Women’s Excellence in Bladder Control is a comprehensive ... leakage or problems with overall control of their bladder. ...
(Date:5/24/2015)... EnviroLeather™ by LDI, a leader ... a classic, rugged leather grain with enhanced stain ... including ink, to be easily removed. The collection ... corporate, healthcare, hospitality and education environments. , InkGard ... of developing products that are more sustainable, less ...
Breaking Medicine News(10 mins):Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2
... the official congress of the European Association of Echocardiography ... Cardiology, where techniques of non-invasive diagnostic imaging will be ... at this year,s Congress, with the latest evidence highlighting ... with such rapid development in imaging techniques, it is ...
... National ... away 10,000 free business card pens. , ... (PRWEB) December 2, 2009 -- National Pen ( www.pens.com ), a worldwide leading ... , , , ,“We have a new way to promote business that no other company ...
... ... away from users will be available in early 2010 from Aerius International Ltd. ... (PRWEB) December ... users will be available in early 2010 from Aerius International Ltd. The technology was ...
... ... 900 runners and walkers from Las Vegas and around the country will ... Marathon powered by Zappos.com, raising over $3.2 million for the Crohn,s & ... the official charity of the race, the funds will go toward research, ...
... , CHICAGO, Dec. 2 The American Health Information ... Dowling, PhD, will be the next chief executive of ... Dowling,s extensive health information experience includes academia, systems management, ... He is scheduled to take office January 13, ...
... , WASHINGTON, Dec. 2 ... their campaign against the U.S. House bill,s pro-life Stupak-Pitts Amendment. ... Yoest released this statement in response to the abortion lobby,s ... abortion with health care, the feminist groups and the abortion ...
Cached Medicine News:Health News:Media alert: EUROECHO 2009 2Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:New AERIUS Cell Phones Direct Microwave Signals Away from Users 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 3Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 4Health News:Dr. Alan F. Dowling Named AHIMA's Next Chief Executive Officer 2
... sources which are implanted in tissue for ... the prostate. The seeds remain in the ... effect, i.e. after radioactive decay is completed. ... They are supplied in a sterile form. ...
... used in Theraseed devices. It is ... grain of rice, are implanted and ... three months it has given up ... lost almost all of it by ...
Non-sterile oncoseed seeds consists of a welded titanium capsule containing....
Four 62 mirrors give a 360 view of the anterior chamber angle with only a slight lens rotation. Posterior pole can be viewed through center of lens....
Medicine Products: